Core F(B): Synthesis Design
Core F(B): Synthesis Design
批准号:
8130689
负责人:
Michael S VanNieuwenhze
金额:
$46.51万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AgonistBiologicalBiological FactorsCarbonCatalogingCatalogsChargeCollaborationsCommunitiesDevelopmentEnsureFatty AcidsFoundationsGrantLaboratoriesLifeLipid ALipidsLow-Density LipoproteinsMethodsMolecularPathway interactionsPeptidesPhospholipidsProductionResearchRouteSeriesStable Isotope LabelingSynthesis ChemistryWorkanalogarmbasedesignmanufacturing processmeetingsmembermimeticsnoveloxidized lipidoxidized low density lipoproteinstability testing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Lipid Synthesis Core (Core F) will serve the LIPID MAPS Consortium by providing synthetic chemistry
support for the Lipidomic Core groups. Core F is composed of two sub-Cores: Lipid Standards, F(A) and
Synthesis Design, F(B). The Lipid Standards sub-Core is represented by Avanti Polar Lipids, Inc. This sub-
Core will serve as the manufacturing arm of the LIPID MAPS consortium, and as such has the responsibility
to (a) design and execute synthetic routes to novel lipids discovered by the consortium, (b) produce novel
agonists, such as Kdo2-Lipid A, (c) produce lipid products that can be used as internal standards, such as
stable isotope-labeled compounds and compounds containing odd chain fatty acids, (d) produce lipid products
that can be used as primary mass spectrometric standards, such as synthetic analogues of natural products,
(e) develop packaging for mass spectrometric standards with defined concentrations and maximum shelf life,
(f) develop production scale synthesis of the LDL oxidized lipid mimetic developed by Core F(B), and (g)
continue the production and stability testing of products developed in the previous grant period. All of the
compounds manufactured and characterized will be made available to the consortium members at no charge,
while the larger lipid community will have access to these products through the Avanti catalog.
The Synthesis Design sub-Core will develop synthetic pathways for novel lipid compounds including the
active agent present in oxidized LDL and odd-carbon chain fatty acids with varying degrees of unsaturation.
Core F(B) will work closely with the Lipid Standards sub-Core to develop production scale manufacturing
processes for these compounds.
The successful completion of the proposed specific aims of Core F will ensure that the Lipidomic Core
groups have pure, stable compounds, which are essential to the completion of the overall objectives of the
Consortium. In essence, the lipid standards provided by Core F are the foundations on which the research
proposed by the other Core laboratories is based.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10343788
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10597980
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Supplement to Chemical Biology Studies of the Dynamics and Inhibition of Peptidoglycan Biosynthesis
-
批准号:10609340
-
项目类别:
-
资助金额:$13.89万
-
财政年份:2020
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
-
批准号:8749603
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2014
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
-
批准号:8913230
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2014
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Novel Inhibitors of Peptidoglycan Biosynthesis Targeting Gram-positive Pathogens
-
批准号:9330172
-
项目类别:
-
资助金额:$34.71万
-
财政年份:2014
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7149128
-
项目类别:
-
资助金额:$11.97万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6868727
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7317819
-
项目类别:
-
资助金额:$30.46万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7546992
-
项目类别:
-
资助金额:$30.35万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:7516583
-
项目类别:
-
资助金额:$20.26万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6986205
-
项目类别:
-
资助金额:$34.28万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Synthesis and Mechanistic Studies of Peptide Antibiotics
-
批准号:6759683
-
项目类别:
-
资助金额:$35.23万
-
财政年份:2004
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7531125
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2003
-
负责人:Michael S VanNieuwenhze
-
依托单位:
EPOXIDATIONS WITH CHIRALLY MODIFIED RU(V)-OXO COMPLEXES
-
批准号:2169827
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1993
-
负责人:Michael S VanNieuwenhze
-
依托单位:
EPOXIDATIONS WITH CHIRALLY MODIFIED RU(V)-OXO COMPLEXES
-
批准号:2169828
-
项目类别:
-
资助金额:$1.09万
-
财政年份:1993
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551352
-
项目类别:
-
资助金额:$24.19万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551318
-
项目类别:
-
资助金额:$18.2万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
CORE Fb
-
批准号:7551335
-
项目类别:
-
资助金额:$19.2万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
Core F(B): Synthesis Design
-
批准号:7932731
-
项目类别:
-
资助金额:$46.87万
-
财政年份:--
-
负责人:Michael S VanNieuwenhze
-
依托单位:
海外基金